Discovery and optimization of a synthetic small protein domain targeting antibodies
Ana Margarida Gonçalves Carvalho Dias1,2, Manuel João Brandão Matos1,2, Cátia Soares1,2
1Associate Laboratory i4HB - Institute for Health and Bioeconomy, Chemistry Department, School of Science and Technology, NOVA University of Lisbon, Campus Caparica, Caparica, Portugal.
Introduction:
Antibodies and their derivatives constitute a crucial class of molecules in modern biotechnology and therapeutic development. Consequently, identifying chemically robust affinity ligands capable of specifically recognizing antibodies remains an important challenge.
Methods:
In this study, an in-house phage display library based on the WW domain scaffold (WWp5_4) was utilized to identify binders against polyclonal human IgG. A lead ligand from clone E6 was selected. To enhance the developability of WW ligands derived from this library, we rationally minimized structural liabilities within the scaffold framework to improve chemical stability and solubility, generating two mutant variants. Furthermore, a head-to-tail dimeric version of the E6 mutant sequence was designed.
Results:
The lead ligand E6 exhibited a dissociation constant of 133 nM. The mutant variants demonstrated a fivefold increase in expression yield compared to the native sequence. Additionally, the dimeric construct showed improved solubility and an estimated dissociation constant of 62 nM toward human IgG.
Conclusions:
This study underscores the potential of small folded protein domains, such as WW domains, as versatile affinity ligands for antibodies and other molecular targets, thereby broadening their applicability in biotechnology and bioengineering.
Related Concept Videos
01:10Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
01:26Drug Discovery: Overview
02:26Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...